Treatment effect of semaglutide 2.4 mg on health‐related quality of life from STEP 1 SF‐6D derived from SF‐36 with Australian weights von Kral, Pavol, Allen, Felicity Liza, Larsen, Sara, Holst‐Hansen, Thomas, Olivieri, Anamaria‐Vera, Manton, Andrew

Volltext

External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions von Lopes, Sandra, Johansen, Pierre, Lamotte, Mark, McEwan, Phil, Olivieri, Anamaria-Vera, Foos, Volker

Volltext

The Correlation Between Body Mass Index and Health-Related Quality of Life: Data from Two Weight Loss Intervention Studies von Kral, Pavol, Holst-Hansen, Thomas, Olivieri, Anamaria V., Ivanescu, Cristina, Lamotte, Mark, Larsen, Sara

Volltext

Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom von Sandhu, Hera, Xu, Weiwei, Olivieri, Anamaria-Vera, Lübker, Christopher, Smith, Inger, Antavalis, Vasileios

Volltext

Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective von Olivieri, Anamaria-Vera, Muratov, Sergey, Larsen, Sara, Luckevich, Maria, Chan, Katalina, Lamotte, Mark, Lau, David C. W.

Volltext

Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions” von Lopes, Sandra, Johansen, Pierre, Lamotte, Mark, McEwan, Phil, Olivieri, Anamaria-Vera, Foos, Volker

Volltext

A novel decision model to predict the impact of weight management interventions: The Core Obesity Model von Lopes, Sandra, Meincke, Henrik H., Lamotte, Mark, Olivieri, Anamaria‐Vera, Lean, Michael E. J.

Volltext

Cost-effectiveness of Semaglutide 2.4 mg in chronic weight management in Portugal von Silva Miguel, Luís, Soares, Mariana, Olivieri, Anamaria, Ribeiro Pimenta Sampaio, Filipa de Jesus, Lamotte, Mark, Shukla, Suramya, Conde, Vasco, Freitas, Paula, Costa, João, Borges, Margarida

Volltext

Assessing the health and economic burden of obesity-related complications in East-Asian populations: implementation of risk equations in the Core Obesity Model for Japan and model... von Tatsuno, Ichiro, Gerlier, Laetitia, Olivieri, Anamaria-Vera, Baker-Knight, James, Lamotte, Mark

Volltext

Treatment effect of semaglutide 2.4mg on health‐related quality of life from STEP 1 SF‐6D derived from SF‐36 with Australian weights von Kral, Pavol, Allen, Felicity Liza, Larsen, Sara, Thomas Holst‐Hansen, Anamaria‐Vera Olivieri, Manton, Andrew

Volltext

Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal von Miguel, Luis Silva, Soares, Mariana, Olivieri, Anamaria, Sampaio, Filipa, Lamotte, Mark, Shukla, Suramya, Conde, Vasco, Freitas, Paula, Costa, Joao, Borges, Margarida

Volltext bestellen